Welcome to the Sonic Revolution

A new category in nervous system regulation

Sonocea is a neuroscience technology company using precisely structured sound to support nervous system regulation.

Our proprietary Sonic Augmentation Technology™ (SAT) uses a novel signal-generation architecture to create structured acoustic environments designed to support autonomic regulation, recovery and performance.

One platform
Multiple applications
Measurable outcomes
The Problem

Nervous system regulation affects how we feel, recover and perform

How well we regulate our state underpins how we recover, perform and respond to our environment. 

When the autonomic nervous system struggles to adapt efficiently to changing demands, the effects can be seen across sleep, recovery, attention, resilience and readiness.

In performance, healthcare, and high-pressure environments, supporting nervous system regulation has become increasingly important.

Yet most available approaches are invasive, effort-dependent, compliance-heavy, pharmacological, or difficult to deliver at scale.

Introducing Sonocea

A new approach to nervous system regulation

One platform
Multiple applications
Measurable outcomes

Sonocea combines proprietary acoustic signal-generation architecture and neuroscience into a scalable platform for nervous system regulation.

Powered by Sonic Augmentation Technology™ (SAT™), the platform delivers structured acoustic interventions designed to support autonomic regulation, recovery and performance. 

Not music
Designed to support physiology, not entertain.
Not music
Designed to support physiology, not entertain.
Simple
Press play. Listen.
Simple
Press play. Listen.
Non-invasive
No wearables. No implants. No specialist hardware.
Non-invasive
No wearables. No implants. No specialist hardware.
Measurable
Clinically studied. Biologically measured.
Measurable
Clinically studied. Biologically measured.
Scalable
One platform. Multiple applications.
Scalable
One platform. Multiple applications.

How

It Works

How

It Works

Mechanism

A new architecture for structured sound

Sonic Augmentation Technology (SAT) uses a proprietary, patent-pending signal-generation control architecture to create precisely structured acoustic input designed to support autonomic regulation.

This structured sound is processed through neural pathways involved in arousal, attention and state regulation, providing a route to state-related neural networks.

Delivered through an app, partner platform, headphones or speakers, SAT is designed to scale across applications and listening environments.

One platform.
Tailored to people, purpose and place

Simple, Accessible Delivery 

Sonocea is simple to access – just press play and listen. 

Applications can be configured for different users, objectives and contexts - from regulation and recovery to readiness and performance.

Sonocea can be delivered wherever it’s needed: the same platform works across performance, healthcare, high-pressure workplaces and the built environment. 

The

Science

The

Science

Clinically studied. Biologically measured.
Independently evaluated

Sonic Augmentation Technology has been evaluated through independent research studies conducted by leading academic, medical and defense research organizations.  

Measurable changes have been observed after a single 15-minute session and across four weeks of repeated use.

In 88.5% of participants

Improved biobehavioral state in 15 minutes

University of Florida College of Medicine (100 out of 113)

In 72.7% of participants

Increased oxytocin in 15 minutes

University of Florida College of Medicine (24 out of 33)

Observed over four weeks

Symptoms improve with daily use

US Federal Research Long COVID Program n=250

Across the research program, outcomes have been evaluated using biological measures alongside validated clinical and behavioral measures.

Supporting publications and study summaries are available on request.

Peer-reviewed publication in Frontiers in Psychiatry (2026).

Peer-reviewed publication in Frontiers in Psychiatry (2026).

A growing range of applications

From established programs to emerging opportunities, our technology can be deployed across applications spanning performance, resilience, health and recovery.

Performance

Supporting readiness and recovery in elite sport and other high-performance environments.

Performance

Supporting readiness and recovery in elite sport and other high-performance environments.

Frontline Resilience

Supporting regulation, recovery and readiness in high-pressure environments.

Frontline Resilience

Supporting regulation, recovery and readiness in high-pressure environments.

Physical Spaces

Designing environments that positively influence how people transition, experience and connect through Sonocea SX.

Physical Spaces

Designing environments that positively influence how people transition, experience and connect through Sonocea SX.

Women's Vitality

Exploring regulation across key life stages where nervous system function influences well-being and quality of life.

Women's Vitality

Exploring regulation across key life stages where nervous system function influences well-being and quality of life.

Women's Vitality

Exploring regulation across key life stages where nervous system function influences well-being and quality of life.

Supportive Care

Helping patient rehabilitation and recovery alongside established clinical pathways.

Supportive Care

Helping patient rehabilitation and recovery alongside established clinical pathways.

Partnerships

Partnerships

Built through partnerships. Designed to scale

Sonocea collaborates with leading academic, medical, defense and commercial partnerships to accelerate the science, application and deployment of acoustic neuroscience. 

Discover

Research and clinical evaluation.

Deploy

Healthcare and performance delivery and implementation.

Design

Immersive experiences and the built environment.

Work with Sonocea

We're always interested in talking to organizations that share our commitment to advancing nervous system regulation through evidence-based acoustic technology.

Featured Partner:
Unyte Health

Unyte Health is an independent organization licensed to deliver Rest & Restore Protocol™ which incorporates Sonocea technology.

Healthcare professionals access Rest & Restore Protocol for use within established therapeutic frameworks following appropriate training. 

Professionals interested in training, certification or access should visit Unyte Health

About

Us

About

Us

Born from Five Decades of Neuroscientific Research

Sonocea was founded at the intersection of behavioral neuroscience and acoustic innovation to explore a simple but powerful question:

What if sound could be engineered to systematically support nervous system regulation at scale?

That question brought together neuroscientist Professor Stephen W. Porges, whose pioneering work transformed scientific understanding of the autonomic nervous system, and Anthony Gorry, whose expertise in sound and technology enabled that science to become a scalable platform.

Today, that collaboration continues to shape every aspect of the science, technology and commercial development at Sonocea.

Scientific Leadership. Global Organization

Sonocea exists to unlock the scientific potential of sound to improve health, recovery and human performance at scale.

It combines world-leading neuroscience with expertise in technology, healthcare and commercial innovation.

Incorporated in Delaware as Sonocea Inc, Sonocea operates with offices in Florida and London, and a multidisciplinary team across the US and Europe.

The company is supported by an internationally recognized scientific advisory board and operates within established research, ethical and institutional governance frameworks.

Leadership

Combining world-leading neuroscience with commercial execution

Sonocea brings together expertise in neuroscience, medicine, technology, product development and commercialization to build a new category in nervous system regulation.

Anthony Gorry

Co-Founder & Chief Executive Officer

Co-inventor with Professor Stephen Porges. Twenty years building and commercializing audio, technology and immersive experiences, now applying that expertise to software-delivered nervous-system technology.

Read more

Anthony Gorry
Co-Founder & Chief Executive Officer
Read bio

Professor Stephen W. Porges, PhD

Co-Founder & Chief Science Officer

World-leading neuroscientist with five decades studying the autonomic nervous system, guiding the scientific foundation and research development of Sonocea.

Read more

Professor Stephen W. Porges, PhD
Co-Founder & Chief Science Officer
Read bio
Sarah Underwood
Co-Founder and Chief Operating Officer
Sarah Underwood
Co-Founder and Chief Operating Officer
Dr. Peter Staats,
MD MBA FIPP ABIPP
Chief Medical Advisor
Dr. Peter Staats,
Chief Medical Advisor
Ryan Schmaltz
Growth Advisor, US
Ryan Schmaltz
Growth Advisor, US
Adam Kamruddin
Growth Advisor, UK
Adam Kamruddin
Growth Advisor, UK
Clare Hindley
Marketing & Comms Advisor
Clare Hindley
Marketing & Comms Advisor
Stefan Traykovski 
Technology Advisor
Stefan Traykovski 
Technology Advisor
Charles Vivian
Fractional Chief Financial Officer
Charles Vivian
Fractional Chief Financial Officer
Charles Vivian
Fractional CFO

Ready to explore what's possible?

Whether you're a healthcare provider, performance organization, researcher or design partner, we'd love to discuss how Sonocea can support your objectives.

advisory board:

World-class scientific advisory board aligned to priority markets

Strengthening the pathway from research to real-world environments.

Dr David M Steinhorn, MD
Palliative & Integrative Care Advisor
Pediatrician and nationally recognized leader in palliative, hospice and integrative medicine, with decades of experience developing patient-centered care programs. He brings expertise in translating non-invasive supportive approaches into real-world clinical and complex-care environments.
Dr David M Steinhorn, MD
Palliative & Integrative Care Advisor
C. Sue Carter, PhD
Women’s Health & Social Biology Advisor
Internationally recognized scientist whose pioneering research established key roles for oxytocin and vasopressin in social bonding, stress regulation and reproductive biology. Her work provides a scientific foundation for Sonocea’s exploration of women’s health, social well-being and oxytocin-related effects.
C. Sue Carter, PhD
Women’s Health & Social Biology Advisor
Robert K. Naviaux, MD PhD
Metabolic & Complex Chronic Conditions Advisor
Professor of Genetics at UC San Diego and internationally recognized authority in mitochondrial medicine and metabolism who coined and developed the Cell Danger Response framework. He brings a molecular and metabolic perspective to complex chronic conditions, physiological dysregulation and recovery.
Robert K. Naviaux, MD PhD
Metabolic & Complex Chronic Conditions Advisor
Robert Dantzer, DVM PhD
Oncology Supportive Care & Fatigue Advisor
Professor at MD Anderson and internationally recognized authority on inflammation, brain–immune interactions, sickness behavior and cancer-related fatigue. His work informs Sonocea’s exploration of fatigue, symptom burden and recovery within oncology and supportive care.
Robert Dantzer, DVM PhD
Oncology Supportive Care & Fatigue Advisor
Dr. Julie R. Korenberg, PhD
Neurodevelopment & Genetics Advisor
Professor of Pediatrics and internationally recognized physician-scientist in human genetics, neurodevelopment and the biology of social behavior. Her expertise informs Sonocea’s longer-term exploration of neurodevelopmental applications and genetically and neurologically diverse populations.
Dr. Julie R. Korenberg, PhD
Neurodevelopment & Genetics Advisor
Dr David M Steinhorn, MD
Palliative & Integrative Care Advisor
Pediatrician and nationally recognized leader in palliative, hospice and integrative medicine, with decades of experience developing patient-centered care programs. He brings expertise in translating non-invasive supportive approaches into real-world clinical and complex-care environments.
Dr David M Steinhorn, MD
Palliative & Integrative Care Advisor
C. Sue Carter, PhD
Women’s Health & Social Biology Advisor
Internationally recognized scientist whose pioneering research established key roles for oxytocin and vasopressin in social bonding, stress regulation and reproductive biology. Her work provides a scientific foundation for Sonocea’s exploration of women’s health, social well-being and oxytocin-related effects.
C. Sue Carter, PhD
Women’s Health & Social Biology Advisor

Frequently Asked Questions

How do you pronounce Sonocea®?

How do you pronounce Sonocea®?

What is acoustic neuroscience?

What is acoustic neuroscience?

What is Sonic Augmentation Technology™ (SAT™)?

What is Sonic Augmentation Technology™ (SAT™)?

What evidence supports Sonocea?

What evidence supports Sonocea?

How is Sonocea different from music, meditation or focus audio?

How is Sonocea different from music, meditation or focus audio?

Is Sonocea a medical device?

Is Sonocea a medical device?

Is Sonocea® safe?

Is Sonocea® safe?

How is Sonocea delivered?

How is Sonocea delivered?

How can my organization work with Sonocea?

How can my organization work with Sonocea?

Contact us

Stay informed

Subscribe to our mailing list to receive the latest news and insights from Sonocea.

Contact us

Stay informed

Subscribe to our mailing list to receive the latest news and insights from Sonocea.

Contact us

Stay informed

Subscribe to our mailing list to receive the latest news and insights from Sonocea.

© 2026 Sonocea Inc. All rights reserved.
Sonocea® is a registered trademark of Sonocea Group Limited.
Sonic Augmentation Technology™ and Sonostasis® are trademarks of Sonocea Group Limited.
© 2026 Sonocea Inc. All rights reserved.
Sonocea® is a registered trademark of Sonocea Group Limited.
Sonic Augmentation Technology™ and Sonostasis® are trademarks of Sonocea Group Limited.

©2025 Sonocea® Inc